| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |